Kingsview Wealth Management’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,959
Closed -$32K 889
2021
Q3
$32K Sell
10,959
-3,445
-24% -$10.1K ﹤0.01% 829
2021
Q2
$56K Sell
14,404
-1,259
-8% -$4.9K ﹤0.01% 849
2021
Q1
$52K Sell
15,663
-349
-2% -$1.16K ﹤0.01% 795
2020
Q4
$45K Buy
16,012
+3,100
+24% +$8.71K ﹤0.01% 685
2020
Q3
$32K Buy
12,912
+2,700
+26% +$6.69K ﹤0.01% 597
2020
Q2
$139K Buy
+10,212
New +$139K 0.01% 549
2019
Q3
Sell
-10,877
Closed -$53K 420
2019
Q2
$53K Sell
10,877
-187
-2% -$911 0.01% 404
2019
Q1
$91K Buy
+11,064
New +$91K 0.01% 436